Corporate News 01-Nov-22
Alembic Pharmaceuticals to table results
On 11 November 2022
Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2022.
Previous News
Alembic Pharmaceuticals consolidated net profit rises 2.41% in the September 2023 quarter
( Results - Announcements 07-Nov-23 15:08 )
Alembic Pharmaceuticals receives EIR for its Injectable Facility at Karkhadi
( Corporate News - 16-Feb-23 15:25 )
Alembic Pharma records 48% growth in Q3 PAT
( Hot Pursuit - 05-Feb-24 16:29 )
Alembic Pharma's oncology formulation facility undergoes USFDA audit
( Corporate News - 09-Mar-24 12:26 )
Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
( Corporate News - 18-Jun-24 18:52 )
Volumes spurt at Alembic Pharmaceuticals Ltd counter
( Hot Pursuit - 29-Jun-22 11:00 )
Alembic Pharma gains after USFDA tentative nod for Acalabrutinib capsules
( Hot Pursuit - 19-Jan-23 14:12 )
Volumes soar at Aditya Birla Fashion & Retail Ltd counter
( Hot Pursuit - 08-May-23 14:30 )
Alembic Pharmaceuticals receives USFDA approval for Mesalamine ER Capsules
( Corporate News - 02-Nov-22 09:40 )
Alembic Pharmaceuticals receives USFDA approval for Prazosin Hydrochloride Capsules
( Corporate News - 08-Mar-23 09:14 )
Alembic Pharma announces US FDA nod for topical corticosteroid
( Hot Pursuit - 25-Apr-22 11:32 )
Other Stories
Board of Essen Speciality Films recommends Final Dividend
29-Jun-24 13:54
Haridas Kanani divests 5.67% stake in Neogen Chemicals
29-Jun-24 12:22
Vodafone Idea launches new plans
29-Jun-24 12:20
GE Power India wins orders worth Rs 12 cr
29-Jun-24 12:00
Diamines & Chemicals appoints VP Manufacturing
29-Jun-24 11:51
Board of REC approves incorporation of project specific SPVs
29-Jun-24 11:48
Surya Roshni wins order of Rs 53 cr from Govt. of Odisha
29-Jun-24 11:05
Macro Intl. revises board meeting date
29-Jun-24 11:01
NOCIL announces cessation of directors
29-Jun-24 10:56
Orient Cement acquires 28.52% stake in Ardeur Renewables
29-Jun-24 10:43
Back
Top
